Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy

BACKGROUND: China has a high prevalence of hepatitis B virus (HBV), but most chronic hepatitis B (CHB) patients do not receive standardized antiviral therapy. There are few relevant reports addressing the outcomes of the large number of CHB patients who do not receive antiviral therapy. AIM: To obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiao-Yan, Huang, Bing, Huang, Dan-Ping, Wei, Chun-Shan, Zhong, Wei-Chao, Peng, De-Ti, Huang, Fu-Rong, Tong, Guang-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985729/
https://www.ncbi.nlm.nih.gov/pubmed/33776376
http://dx.doi.org/10.3748/wjg.v27.i11.1101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985729/
https://www.ncbi.nlm.nih.gov/pubmed/33776376
http://dx.doi.org/10.3748/wjg.v27.i11.1101

Ejemplares similares